Screening tests for the evaluation of cognitive impairment in multiple sclerosis patients

Screening tests for the evaluation of cognitive impairment in multiple sclerosis patients

Multiple sclerosis (MS), the most common autoimmune neurological disease of young people, is a significant burden for the patient, significantly decreasing the quality of life. Besides motor deficits, sensory problems, and vision loss, in recent years, neurologists have focused also on the cognitive...

Full description

Bibliographic Details
Main Authors:	Alina Ioana Nacu-Florescu, Oliver Daniel Schreiner, Thomas Gabriel Schreiner
Format:	Article
Language:	English
Published:	Amaltea Medical Publishing House 2022-12-01
Series:	Romanian Journal of Neurology
Subjects:	multiple sclerosis cognitive impairment montreal cognitive assessment mini-mental state examination screening
Online Access:	https://rjn.com.ro/articles/2022.4/RJN_2022_4_Art-01.pdf

Similar Items

Validation of a modified Chinese version of Mini‐Addenbrooke's Cognitive Examination for detecting mild cognitive impairment
by: Feng‐Feng Pan, et al.
Published: (2022-01-01)

Validation of Brain Health Test-7 for Detecting Patients with Mild Cognitive Impairment and Early Dementia
by: Mei- Xian Loi, et al.
Published: (2020-01-01)

Quick screening of cognitive function in Indian multiple sclerosis patients using Montreal cognitive assessment test-short version
by: Darshpreet Kaur, et al.
Published: (2013-01-01)

Evaluation of the Mini-Mental State Examination and the Montreal Cognitive Assessment for Predicting Post-stroke Cognitive Impairment During the Acute Phase in Chinese Minor Stroke Patients
by: Yueli Zhu, et al.
Published: (2020-08-01)

Montreal Cognitive Assessment as Screening Measure for Mild and Major Neurocognitive Disorder in a Chilean Population
by: Sebastian Bello-Lepe, et al.
Published: (2020-10-01)

Cognitive Impairment in Young Multiple Sclerosis and Essential Tremor Patients: A Comparative Study
by: Hakan Serdar Şengül, et al.
Published: (2016-09-01)

Usefulness of the Cognitive Composition Test as an Early Discriminator of Mild Cognitive Impairment
by: Yoshiki Tamaru, et al.
Published: (2023-02-01)

Soluble ST2 and risk of cognitive impairment after acute ischemic stroke: a prospective observational study
by: Yinwei Zhu, et al.
Published: (2021-05-01)

Development of a Brief Cognitive Screening Tool for Predicting Postoperative Delirium in Patients with Parkinson’s Disease: A Secondary Analysis
by: Zhou Y, et al.
Published: (2023-09-01)

Comparison between the Mini-Mental State Examination and Montreal Cognitive Assessment as a Cognitive Screening Tool in Patients with Human Immunodeficiency Virus-Associated Neurocognitive Disorders
by: Paulo Roberto Brito-Marques, et al.
Published: (2019-12-01)

Assessment of Cognitive Functioning in Adult Women with Low Vitamin D Level Using Mini Mental State Examination and Montreal Cognitive Assessment
by: Aslı Gençay Can, et al.
Published: (2017-04-01)

Using the Oxford Cognitive Screen to Detect Cognitive Impairment in Stroke Patients: A Comparison with the Mini-Mental State Examination
by: Mauro Mancuso, et al.
Published: (2018-02-01)

The Utility of the Mini-Addenbrooke’s Cognitive Examination as a Screen for Cognitive Impairment in Elderly Patients with Chronic Kidney Disease and Diabetes
by: Peter Hobson, et al.
Published: (2016-12-01)

Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
by: María A. Rodríguez‐Santiago, et al.
Published: (2024-01-01)

Six-item cognitive impairment test (6-CIT)’s accuracy as a cognitive screening tool: best cut-off levels in emergency department setting
by: Francesco Salis, et al.
Published: (2023-07-01)

Screening for Cognitive Impairment in Multiple Sclerosis with MOCA Test
by: Selma Aksoy, et al.
Published: (2013-06-01)

Proactive Approach in Detecting Elderly Subjects with Cognitive Decline in General Practitioners’ Practices
by: M. Hanzevacki, et al.
Published: (2011-04-01)

Clock Drawing Test: Screening of Cognitive Dysfunction in Patients with Multiple Sclerosis
by: Mohammad-Taghi Saeedi, et al.
Published: (2014-03-01)

Screening for Impaired Cognitive Domains in a Large Parkinson's Disease Population and Its Application to the Diagnostic Procedure for Parkinson's Disease Dementia
by: Kouichi Ohta, et al.
Published: (2014-05-01)

Validation of the Conversion between the Mini-Mental State Examination and Montreal Cognitive assessment in Korean Patients with Parkinson’s Disease
by: Ryul Kim, et al.
Published: (2018-01-01)

A study to evaluate the relationship between diabetes mellitus and cognitive dysfunction
by: Rakesh Kumar Patel, et al.
Published: (2022-09-01)

Clinical Characteristics of Cognitive Impairment and 1-Year Outcome in Patients With Anti-LGI1 Antibody Encephalitis
by: Hai-lun Hang, et al.
Published: (2020-08-01)

Cognitive Impairment in Multiple Sclerosis
by: Trenova Anastasiya G., et al.
Published: (2016-09-01)

Psychometric Properties of the Persian Montreal Cognitive Assessment in Mild Cognitive Impairment and Alzheimer Disease
by: Vahid Rashedi, et al.
Published: (2021-03-01)

Comparing the Diagnostic Accuracy of Two Cognitive Screening Instruments in Different Dementia Subtypes and Clinical Depression
by: Rónán O’Caoimh, et al.
Published: (2019-08-01)

Non-Pharmacological Treatments of Cognitive Impairment in Multiple Sclerosis: A Review
by: Michela Bossa, et al.
Published: (2022-08-01)

The Q* Index: A Useful Global Measure of Dementia Screening Test Accuracy
by: A.J. Larner
Published: (2015-06-01)

Early detection of cognitive impairment in patients with multiple sclerosis
by: Poverennova I.E., et al.
Published: (2017-03-01)

Assessment and Impact of Cognitive Impairment in Multiple Sclerosis: An Overview
by: Miguel Ángel Macías Islas, et al.
Published: (2019-03-01)

Optimal Cutoff Scores for Dementia and Mild Cognitive Impairment in the Brazilian Version of the Montreal Cognitive Assessment among the Elderly
by: Tiago C.C. Pinto, et al.
Published: (2019-02-01)

Diagnostics and clinical usability of the Montreal Cognitive Assessment (MoCA) in amyotrophic lateral sclerosis
by: Edoardo Nicolò Aiello, et al.
Published: (2022-09-01)

Molecular biomarkers and cognitive impairment in multiple sclerosis: A review
by: Sara Esmaeili, et al.
Published: (2023-12-01)

What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation
by: Sarah A. Morrow, et al.
Published: (2023-07-01)

Effect Size (Cohen's d) of Cognitive Screening Instruments Examined in Pragmatic Diagnostic Accuracy Studies
by: Andrew J. Larner
Published: (2014-07-01)

Dynamics and Predictors of Cognitive Impairment along the Disease Course in Multiple Sclerosis
by: Elisabet Lopez-Soley, et al.
Published: (2021-10-01)

Editorial: Cognition in Multiple Sclerosis
by: Rosa Cortese, et al.
Published: (2021-08-01)

Neurophysiologic tests screening cognitive impairment in idiopathic intracranial hypertension patients
by: Iman A. Elbanhawy, et al.
Published: (2018-04-01)

Magnitude and correlates of cognitive impairment among major depressive disorder patients in Addis Ababa: institution based cross-sectional study
by: Abebe Ambaw, et al.
Published: (2019-03-01)

T‐MoCA: A valid phone screen for cognitive impairment in diverse community samples
by: Mindy J. Katz, et al.
Published: (2021-01-01)

Neurocognition of Aged Patients With Chronic Tinnitus: Focus on Mild Cognitive Impairment
by: Sang-Yeon Lee, et al.
Published: (2020-02-01)